Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Terns Pharmaceuticals (TERN)
NASDAQ:TERN
Terns Pharmaceuticals (TERN) Stock Price & Analysis
114 Followers
TERN Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$3.26 - $14.04
Previous Close$6.56
Volume1.24M
Average Volume (3M)840.16K
Market Cap
$424.12M
Enterprise Value$158.29M
Total Cash (Recent Filing)$266.60M
Total Debt (Recent Filing)$770.00K
Price to Earnings (P/E)-5.2
Beta0.42
Next Earnings
May 13, 2024EPS Estimate
-$0.34Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.27
Shares Outstanding64,651,693
10 Day Avg. Volume806,081
30 Day Avg. Volume840,165
Standard Deviation0.31
R-Squared0.01
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)1.54
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-4.80
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-1.80
Forecast
1Y Price Target
$14.92Price Target Upside127.44% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering7
Terns Pharmaceuticals News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
TERN FAQ
What was Terns Pharmaceuticals’s price range in the past 12 months?
Terns Pharmaceuticals lowest stock price was $3.26 and its highest was $14.04 in the past 12 months.
What is Terns Pharmaceuticals’s market cap?
Currently, no data Available
When is Terns Pharmaceuticals’s upcoming earnings report date?
Terns Pharmaceuticals’s upcoming earnings report date is May 13, 2024 which is in 24 days.
How were Terns Pharmaceuticals’s earnings last quarter?
Terns Pharmaceuticals released its earnings results on Mar 14, 2024. The company reported -$0.29 earnings per share for the quarter, beating the consensus estimate of -$0.293 by $0.003.
Is Terns Pharmaceuticals overvalued?
According to Wall Street analysts Terns Pharmaceuticals’s price is currently Undervalued.
Does Terns Pharmaceuticals pay dividends?
Terns Pharmaceuticals does not currently pay dividends.
What is Terns Pharmaceuticals’s EPS estimate?
Terns Pharmaceuticals’s EPS estimate is -$0.34.
How many shares outstanding does Terns Pharmaceuticals have?
Terns Pharmaceuticals has 64,651,695 shares outstanding.
What happened to Terns Pharmaceuticals’s price movement after its last earnings report?
Terns Pharmaceuticals reported an EPS of -$0.29 in its last earnings report, beating expectations of -$0.293. Following the earnings report the stock price went up 7.303%.
Which hedge fund is a major shareholder of Terns Pharmaceuticals?
Among the largest hedge funds holding Terns Pharmaceuticals’s share is Fairmount Funds Management Llc. It holds Terns Pharmaceuticals’s shares valued at 13M.
---
Terns Pharmaceuticals Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$14.92 (127.44% Upside)
$14.92 (127.44% Upside)
Blogger Sentiment
Bullish
TERN Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 553.6K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 3.6%
Last 30 Days ▲ 14.1%
Last 30 Days ▲ 14.1%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-38.63%
12-Months-Change
Fundamentals
Return on Equity
-33.89%
Trailing 12-Months
Asset Growth
-6.45%
Trailing 12-Months
Company Description
Terns Pharmaceuticals
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases.
---
TERN Stock 12 Months Forecast
Average Price Target
$14.92
▲(127.44% Upside)
Technical Analysis
Assembly Biosciences
―
Crispr Therapeutics AG
―
Exelixis
―
Arrowhead Pharmaceuticals
―
Best Analysts Covering TERN
1 Year
1 Year Success Rate
4/7 ratings generated profit
1 Year Average Return
+9.23%
reiterated a buy rating last month
Copying Etzer Darout's trades and holding each position for 1 Year would result in 57.14% of your transactions generating a profit, with an average return of +9.23% per trade.
---